This topic contains a solution. Click here to go to the answer

Author Question: In what clinical condition has pressure-controlled ventilation with a prolonged inspiratory time ... (Read 29 times)

Coya19@aol.com

  • Hero Member
  • *****
  • Posts: 601
In what clinical condition has pressure-controlled ventilation with a prolonged inspiratory time been shown to be helpful?
 
  a. ARDS/acute lung injury
  b. Pulmonary embolism
  c. Bilateral pneumonia
  d. Severe pulmonary fibrosis

Question 2

What is the primary concern when using proning to improve oxygenation in the patient with ARDS?
 
  a. Sudden increase in PaCO2
  b. Displacement of tubes and lines
  c. Pneumothorax
  d. Hemodynamic compromise



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

spencer.martell

  • Sr. Member
  • ****
  • Posts: 342
Answer to Question 1

ANS: A
Pressure-control ventilation with prolonged inspiratory time has been associated with improve-ment in PaO2 in patients with acute lung injury/ARDS.

Answer to Question 2

ANS: B
Care must be taken to ensure that endotracheal tubes, intravenous lines, and catheters are not blocked or dislodged.




Coya19@aol.com

  • Member
  • Posts: 601
Reply 2 on: Jul 16, 2018
Thanks for the timely response, appreciate it


tranoy

  • Member
  • Posts: 344
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Women are 50% to 75% more likely than men to experience an adverse drug reaction.

Did you know?

Amoebae are the simplest type of protozoans, and are characterized by a feeding and dividing trophozoite stage that moves by temporary extensions called pseudopodia or false feet.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library